US Patent 9731000 Modified RSV F proteins and methods of their use
Patent 9731000 was granted and assigned to Novavax on August, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+273 characters)
Article
Patent abstract
The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Bin Zhou0
Gale Smith0
Michael J. Massare0
Peter M. Pushko0
Ye Liu0
Yingyun Wu0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09731000 Modified RSV F proteins and methods of their use US Patent 9731000 Modified RSV F proteins and methods of their use
Infobox
Patent Number
097310000
Patent Number
97310000
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
097310000
Date of Patent
August 15, 2017
0Patent Application Number
147308050
Date Filed
June 4, 2015
0Patent Primary Examiner
Edits on 14 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09731000 Modified RSV F proteins and methods of their use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09731000
Date of patent
August 15, 2017
Patent application number
14730805
Date Filed
June 4, 2015
Patent primary examiner
Find more entities like US Patent 9731000 Modified RSV F proteins and methods of their use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
